探索代谢功能障碍相关的脂肪性肝病与FAM19A5因子之间的相关性:多变量线性回归分析
Xiaoyan Huang1, Miaohui Wu2, Zexiang Wu3,4
1Department of Endocrinology and Diabetes Center, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, China.
Medicine
|July 15, 2025
概括
低水平的细胞因子家族与序列相似性19成员A5 (FAM19A5) 与代谢功能障碍相关的脂肪性肝病 (MASLD) 有关. 这表明FAM19A5可能是诊断MASLD的有用生物标志物.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 发现生物标志物的发现.
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及肝脏脂肪的积累,是广泛的代谢问题.
- 序列相似性19家族成员A5 (FAM19A5) 是一种涉及代谢调节的细胞因子.
- 作为MASLD诊断和治疗监测的潜在生物标志物,FAM19A5显示出前景.
研究的目的:
- 为了研究血FAM19A5水平与MASLD之间的关联.
- 评估FAM19A5作为MASLD的潜在诊断生物标志物.
主要方法:
- 一项横截面研究包括37名参与者 (18名MASLD患者,19名对照).
- 使用酶相关免疫吸收试验 (ELISA) 测量了血FAM19A5水平.
- 统计分析包括单变量查,多变量线性回归与混调整,并使用SPSS 26.0.0.逐步变量选择.
主要成果:
- 在FAM19A5水平和MASLD,体重指数和总胆固醇之间观察到显著的负相关性.
- 与健康对照组相比,MASLD患者的血FAM19A5表达显著降低.
- 较低的FAM19A5表达与MASLD的病理生理学有关.
结论:
- FAM19A5可能作为MASLD的新型诊断生物标志物.
- 减少的FAM19A5水平是MASLD的标志.
- 需要对更大的队列进行进一步的研究,以确认因果关系和临床效用.
相关概念视频
01:28Overview of Fatty Acid Metabolism
31.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
31.7K
01:30Liver Physiology
1.3K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.3K
01:24Overview of Lipid Metabolism
2.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.5K
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
206
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
206